These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 7202450)

  • 21. Medical treatment of cystinuria: results of contemporary clinical practice.
    Chow GK; Streem SB
    J Urol; 1996 Nov; 156(5):1576-8. PubMed ID: 8863541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Treatment of cystine calculi with tiopronin (author's transl)].
    Araki T; Tanahashi T; Ishito N; Asahi T; Fujita Y; Kondo K; Oomori H
    Nihon Hinyokika Gakkai Zasshi; 1981 Feb; 72(2):221-36. PubMed ID: 7253355
    [No Abstract]   [Full Text] [Related]  

  • 23. [The use of mercapto-propionyl-glycine in the treatment of cystine lithiasis (author's transl)].
    Dimopoulos C; Stokidis D; Kallistratos G; Sidéris C; Kyriakidis A; Kollias G
    J Urol (Paris); 1981; 87(5):265-8. PubMed ID: 7276604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of clinically normal and cystinuric dogs with 2-mercaptopropionylglycine.
    Hoppe A; Denneberg T; Kågedal B
    Am J Vet Res; 1988 Jun; 49(6):923-8. PubMed ID: 3400930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of health-related quality of life in patients with cystinuria on tiopronin therapy.
    Modersitzki F; Goldfarb DS; Goldstein RL; Sur RL; Penniston KL
    Urolithiasis; 2020 Aug; 48(4):313-320. PubMed ID: 31834425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse events associated with currently used medical treatments for cystinuria and treatment goals: results from a series of 442 patients in France.
    Prot-Bertoye C; Lebbah S; Daudon M; Tostivint I; Jais JP; Lillo-Le Louët A; Pontoizeau C; Cochat P; Bataille P; Bridoux F; Brignon P; Choquenet C; Combe C; Conort P; Decramer S; Doré B; Dussol B; Essig M; Frimat M; Gaunez N; Joly D; Le Toquin-Bernard S; Méjean A; Meria P; Morin D; N'Guyen HV; Normand M; Pietak M; Ronco P; Saussine C; Tsimaratos M; Friedlander G; Traxer O; Knebelmann B; Courbebaisse M;
    BJU Int; 2019 Nov; 124(5):849-861. PubMed ID: 30801923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alternative treatment of cystinuria with alpha-merkaptopropionylglycine, Thiola.
    Denneberg T; Jeppsson JO; Stenberg P
    Proc Eur Dial Transplant Assoc; 1983; 20():427-33. PubMed ID: 6657666
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cystine-lysine-ornithine-argininuria. Current genetic and clinico-therapeutic problems].
    Berio A
    Minerva Pediatr; 1979 Oct; 31(20):1443-52. PubMed ID: 537610
    [No Abstract]   [Full Text] [Related]  

  • 29. Sulfur amino acid metabolism in cystinuria: a biochemical and clinical study of patients.
    Mårtensson J; Denneberg T; Lindell A; Textorius O
    Kidney Int; 1990 Jan; 37(1):143-9. PubMed ID: 2299801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The long-term outcome of cystinuria in Japan.
    Akakura K; Egoshi K; Ueda T; Nozumi K; Kotake T; Masai M; Ito H
    Urol Int; 1998; 61(2):86-9. PubMed ID: 9873246
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of sodium intake on cystinuria with and without tiopronin treatment.
    Lindell A; Denneberg T; Edholm E; Jeppsson JO
    Nephron; 1995; 71(4):407-15. PubMed ID: 8587620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of cystinuria with Thiola (alpha-mercaptopropionyl glycine).
    Remien A; Kallistratos G; Burchardt P
    Eur Urol; 1975; 1(5):227-8. PubMed ID: 1233187
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cystinuria in the dog: clinical studies during 14 years of medical treatment.
    Hoppe A; Denneberg T
    J Vet Intern Med; 2001; 15(4):361-7. PubMed ID: 11467594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dissolution of bilateral staghorn cystine renal calculi.
    Van Dugteren GR; Wiggelinkhuizen J
    Arch Dis Child; 1979 Oct; 54(10):795-8. PubMed ID: 41490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Urinary excretion of free cystine and the tiopronin-cysteine-mixed disulfide during long term tiopronin treatment of cystinuria.
    Lindell A; Denneberg T; Jeppsson JO
    Nephron; 1995; 71(3):328-42. PubMed ID: 8569983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoprotection of ovarian follicles of mice against gamma irradiation by MPG (2-mercaptopropionylglycine).
    Kumar A; Devi PU
    J Radiat Res; 1982 Sep; 23(3):306-12. PubMed ID: 7161746
    [No Abstract]   [Full Text] [Related]  

  • 37. Captopril therapy of recurrent nephrolithiasis in a child with cystinuria.
    Sandroni S; Stevens P; Barraza M; Tolaymat A
    Child Nephrol Urol; 1988-1989; 9(6):347-8. PubMed ID: 3078586
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Studies of urinary cystine precipitation in vitro: ontogeny of cystine nephrolithiasis and identification of meso-2,3-dimercaptosuccinic acid as a potential therapy for cystinuria.
    Parvex P; Rozen R; Dziarmaga A; Goodyer P
    Mol Genet Metab; 2003 Dec; 80(4):419-25. PubMed ID: 14654355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Myopathy due to mercaptopropionyl glycine.
    Mansell MA
    Br Med J (Clin Res Ed); 1982 Nov; 285(6351):1356-7. PubMed ID: 6812710
    [No Abstract]   [Full Text] [Related]  

  • 40. Nephrotic syndrome induced by tiopronin: association with the HLA-DR3 antigen.
    Salvarani C; Macchioni P; Rossi F; Iori I; Filippi G
    Arthritis Rheum; 1985 May; 28(5):595-6. PubMed ID: 3873945
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.